<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112442248</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112442248</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Data Mining of Spatial–Temporal Expression of Genes in the Human Endometrium During the Window of Implantation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Dan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112442248">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Cuixiang</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1933719112442248">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Chengbin</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-1933719112442248">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dai</surname>
<given-names>Haiyan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1933719112442248">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Wei</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112442248">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719112442248"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112442248">
<label>1</label>Institute of Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China</aff>
<aff id="aff2-1933719112442248">
<label>2</label>Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China</aff>
<aff id="aff3-1933719112442248">
<label>3</label>Health Center for Women and Children, Chang ning district, Shanghai, China</aff>
<aff id="aff4-1933719112442248">
<label>4</label>Pu Nan Hospital, Shanghai, China</aff>
<author-notes>
<corresp id="corresp1-1933719112442248">Wei Zhang, Institute of Obstetrics and Gynecology Hospital, Fudan University, 413 Zhaozhou Road, Shanghai, China, 200011 Email: <email>zhang.wei.fudan@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>10</issue>
<fpage>1085</fpage>
<lpage>1098</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>Previous studies of microarrays have produced mass data that are far from fully applied. To make full use of the available mass data and to avoid redundancy and unnecessary waste, we employed bioinformatics tools GeneSifter and Ingenuity Pathway Analysis (IPA) to mine and annotate 45 microarrays related to endometrium receptivity from GEO (Gene Expression Omnibus) database. In total, 1543 gene sets were found to express differentially, of which 148 highly regulated genes were listed as potential biomarkers of the receptive endometrium. The function and pathway analysis identified the differentially expressed genes primarily involved in immune response and cell cycle. Two networks related to the cardiovascular system and cancers were generated within the genes which changed more than 10-fold. Nine genes were validated by real-time polymerase chain reaction. It was a meaningful exploration of the existing data to acquire useful and reliable information, and our results undoubtedly provided valuable clues for further studies.</p>
</abstract>
<kwd-group>
<kwd>data mining</kwd>
<kwd>the window of implantation</kwd>
<kwd>endometrial receptivity</kwd>
<kwd>biomarker</kwd>
<kwd>bioinformatics</kwd>
<kwd>gene expression profile</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112442248">
<title>Introduction</title>
<p>Successful implantation demands an outstanding synchronization between the embryonic development and the differentiation of endometrium. The viable blastocyst and the receptive endometrium are the two necessary conditions.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112442248">1</xref>
</sup> The endometrium is receptive only during the window of implantation which approximately lasts 4 days (day 20-23), equal to the time of middle secretory phase in a normal 28-day menstrual cycle in human beings.<sup>
<xref ref-type="bibr" rid="bibr2-1933719112442248">2</xref>
</sup> In the process of receptivity establishment, the endometrium undergoes extensive morphological, physiological, and molecular biological changes to facilitate embryo implantation, which are precisely regulated by endocrine, paracrine, and autocrine signals.<sup>
<xref ref-type="bibr" rid="bibr3-1933719112442248">3</xref>
<xref ref-type="bibr" rid="bibr4-1933719112442248"/>
<xref ref-type="bibr" rid="bibr5-1933719112442248"/>
<xref ref-type="bibr" rid="bibr6-1933719112442248"/>
<xref ref-type="bibr" rid="bibr7-1933719112442248"/>
<xref ref-type="bibr" rid="bibr8-1933719112442248"/>–<xref ref-type="bibr" rid="bibr9-1933719112442248">9</xref>
</sup> Disturbance of endometrial receptivity composes one of the major factors of assisted reproductive technology (ART) failure and unexplained infertility. If we can find ways to pinpoint the restricted period and ensure the embryo transfer with the right time of optimal endometrial receptivity, the ART, the diagnosis and treatment of unexplained infertility can be significantly promoted. Therefore, there is an underlying necessity to discover specific markers that may serve as molecular targets for imaging the endometrial receptivity. To achieve this, researchers have made great efforts in recent years. The past two decades have witnessed an explosive growth in the amount of genomic studies, which resulted in unprecedented amount of data accumulated.<sup>
<xref ref-type="bibr" rid="bibr10-1933719112442248">10</xref>
<xref ref-type="bibr" rid="bibr11-1933719112442248"/>
<xref ref-type="bibr" rid="bibr12-1933719112442248"/>
<xref ref-type="bibr" rid="bibr13-1933719112442248"/>
<xref ref-type="bibr" rid="bibr14-1933719112442248"/>
<xref ref-type="bibr" rid="bibr15-1933719112442248"/>
<xref ref-type="bibr" rid="bibr16-1933719112442248"/>–<xref ref-type="bibr" rid="bibr17-1933719112442248">17</xref>
</sup> Despite vigorous research efforts, the reliable diagnostic markers are still lacking and the molecular mechanism under the endometrial receptivity remains unclear.</p>
<p>Bioinformatics, a newly emerging cross-discipline which employs computer technologies and statistical methods to manage and analyze the huge volume of biological data, has been widely used for biomarker discovery, prognosis, and analysis of molecular mechanism of diseases or special conditions.<sup>
<xref ref-type="bibr" rid="bibr18-1933719112442248">18</xref>
<xref ref-type="bibr" rid="bibr19-1933719112442248"/>
<xref ref-type="bibr" rid="bibr20-1933719112442248"/>–<xref ref-type="bibr" rid="bibr21-1933719112442248">21</xref>
</sup> The development of bioinformatics would open the possibility for efficiently utilizing the unprecedented amount of the previous data. In the present study, therefore, we sought to get more valuable and accurate information by integrating and analyzing the mass existing data, which may help discover specific biomarkers and illuminate the molecular mechanism of the receptive endometrium.</p>
</sec>
<sec id="section2-1933719112442248" sec-type="methods">
<title>Methods</title>
<sec id="section3-1933719112442248">
<title>Data Collection</title>
<p>After searching the two biggest microarray data repositories, GEO (http:// www.ncbi.nlm.nih.gov/geo/) and ArrayExpress (http://www.ebi.ac.uk/microarray-as/ae/),<sup>
<xref ref-type="bibr" rid="bibr18-1933719112442248">18</xref>
</sup> total of 45 samples from 3 studies (GSE 4888,<sup>
<xref ref-type="bibr" rid="bibr17-1933719112442248">17</xref>
</sup> GSE 6364,<sup>
<xref ref-type="bibr" rid="bibr22-1933719112442248">22</xref>
</sup> and GSE 7305<sup>23</sup>) using the same platform Affymetrix Human Genome U133 plus 2.0 Array (HG-U133_Plus_2, total 54 675 probe sets) were selected for analysis, of which 17 were collected from the proliferative phase, 6 from early secretory phase, 16 from mid-secretory phase, and 6 from late secretory phases (<xref ref-type="table" rid="table1-1933719112442248">Table 1</xref>). The data of disease groups from GSE6364 and GSE7305 were removed and the remaining were all the normal samples. All the endometrial biopsies were obtained by pipelle catheter, biopsy, or curetting hysterectomy specimens from women with normal menstrual cycle and without steroid hormone medications within 3 months. The indications for the operative procedures in which the samples were obtained included uterine prolapsed, uterine leiomyomata, normal volunteers, pelvic pain, and ovarian cyst. None of the participants had endometriosis. The classification was performed against pathological criteria. Total RNAs were extracted, amplified, and hybridized onto Affymetrix microarrays, and the chips were scanned using the HR3000 scanner from Affymetrix.</p>
<table-wrap id="table1-1933719112442248" position="float">
<label>Table 1.</label>
<caption>
<p>Source of Samples in this Study</p>
</caption>
<graphic alternate-form-of="table1-1933719112442248" xlink:href="10.1177_1933719112442248-table1.tif"/>
<table>
<thead>
<tr>
<th>Menstrual Phase</th>
<th>Series</th>
<th>Samples</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3">PE</td>
<td>GSE 4888</td>
<td>GSM109814_598, GSM109815_M165, GSM109816_M169, GSM109817_M182</td>
</tr>
<tr>
<td>GSE 6364</td>
<td>GSM150196, GSM150197, GSM150198, GSM150199, GSM150201</td>
</tr>
<tr>
<td>GSE 7305</td>
<td>GSM175776, GSM175777, GSM175780, GSM175781, GSM175782, GSM175783, GSM175784, GSM175785</td>
</tr>
<tr>
<td rowspan="2">ESE</td>
<td>GSE 4888</td>
<td>GSM109820_629, GSM109821_650, GSM109822_664</td>
</tr>
<tr>
<td>GSE 6364</td>
<td>GSM150208, GSM150209, GSM150210</td>
</tr>
<tr>
<td rowspan="2">MSE</td>
<td>GSE 4888 </td>
<td>GSM109824_610, GSM109825_617, GSM109826_626, GSM109827_659, GSM109828_G98A, GSM109829_M153, GSM109830_M158, GSM109831_M163</td>
</tr>
<tr>
<td>GSE 6364 </td>
<td>GSM150220, GSM150221, GSM150222, GSM150223, GSM150224, GSM150225, GSM150226, GSM150227 </td>
</tr>
<tr>
<td>LSE</td>
<td>GSE 4888</td>
<td>GSM109834_442, GSM109835_449, GSM109836_462, GSM109837_576, GSM109838_614, GSM109839_619 </td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112442248">
<p>Abbreviations: PE, proliferative endometrium; ESE, early secretory endometrium; MSE, mid-secretory endometrium and LSE, late secretory endometrium.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-1933719112442248">
<title>Data Analysis</title>
<sec id="section5-1933719112442248">
<title>Identification of differently expressed genes</title>
<p>To determine spatial–temporaral expression of genes in MSE, the downloaded CEL files were uploaded onto GeneSifter program (www.genesifter.net) using robust microarray analysis (RMA) for background adjustment, normalization, and log2 transformation of perfect match values.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112442248">19</xref>
</sup> Project analysis was used to identity differentially expressed genes based on the following parameters: global median normalization, a quality cutoff of 0.75, a fold-change threshold of 2.0, and a Kruskal-Wallis test among groups followed by Benjamini-Hochberg posttest to limit a false discovery rate ≤5%. To further find the most highly changed genes to facilitate biomarker discovery, we adjusted the fold-change threshold from 5 to 10. Principal component analysis (PCA) was used to examine the complexities of the multivariate data.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112442248">20</xref>
</sup> Subsequently, hierarchical clustering (condition tree) was applied to the data files.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112442248">21</xref>,<xref ref-type="bibr" rid="bibr24-1933719112442248">24</xref>
</sup> The chromosome analysis was carried out by another module of Genesifter, which allowed the user to view all the selected genes gathered by chromosome distribution in a project.</p>
</sec>
<sec id="section6-1933719112442248">
<title>Functional analysis of differentially expressed genes</title>
<p>GeneSifter provides gene ontology (GO) analysis tool, a major bioinformatics initiative with the aim of standardizing the representation of gene and gene product attributes across species and databases, which can be used to interpret biological, molecular, and cellular functions of these differentially expressed genes. A <italic>z</italic> score report is provided to statistically evaluate the results, showing how much the ontology is over- or under- represented in a gene list: positive <italic>z</italic> scores indicating the given GO category with more genes meeting the criterion than is expected by chance, as in the case of the negatives, and those near zero suggesting that the number of genes approximates to the expected number.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112442248">17</xref>
</sup>
</p>
</sec>
<sec id="section7-1933719112442248">
<title>Pathway and network analysis</title>
<p>For further understanding their complexity, differentially expressed genes were uploaded onto ingenuity software for analysis (www.ingenuity.com). Canonical pathway analysis identified the pathways from the Ingenuity Pathway Analysis (IPA) library of canonical pathways that were most significant to the data set. The genes from the data set that met the fold-change cutoff of 2 in association with a canonical pathway in Ingenuity Knowledge Base were considered for analysis. The significance of the association between the data set and the canonical pathway was measured in 2 ways: a ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed; Fisher exact test was used to calculate a <italic>P</italic> value determining the probability that the association between the genes in the data set and the canonical pathway is explained by chance alone (www.ingenuity.com company/pdf/Citation Guidelines).<sup>
<xref ref-type="bibr" rid="bibr21-1933719112442248">21</xref>,<xref ref-type="bibr" rid="bibr24-1933719112442248">24</xref>
</sup>
</p>
<p>Network analysis was used to exhibit the relationships between those highly regulated genes. Since the size of the created gene network could potentially be enormous, the number of molecules was limited to 35, leaving only the most important ones based on the number of connections for each focus gene (focus genes = a subset of uploaded significant genes having direct interactions with other genes in the database) to other significant genes.<sup>
<xref ref-type="bibr" rid="bibr25-1933719112442248">25</xref>
</sup> To be concise, a set of data containing the so-called highly regulated genes which changed over 10-fold and corresponding expression values were uploaded for network analysis. Each identifier was mapped to its corresponding object in Ingenuity’s Knowledge Base. The networks of these focus genes were algorithmically generated based on their connectivity.</p>
</sec>
</sec>
<sec id="section8-1933719112442248">
<title>Data Validation</title>
<p>The endometrial samples (n = 18) were obtained from fertile women by pipelle catheter when they underwent colposcopy examination for cervical benign lesions, which was confirmed by pathology. The inclusion criteria for the participants were as follows: aging from 24 to 41 years, having regular cycles (27-33 days), and without steroid hormone medications within 3 months. The procedures were conducted after obtaining a written informed consent from the participants and the study protocol was approved by the Committee of Fudan University Obstetrics and Gynecology Hospital on the Use of Human Subjects in Medical Research. The samples were kept on ice and transported to the laboratory immediately. The portions of tissues were routinely embedded in optimal cutting temperature compound, and then frozen blocks underwent hematoxylin and eosin staining and histological evaluation was conducted blindly by 2 independent pathologists. The specimens were assigned, according to the criteria of Noyes et al,<sup>
<xref ref-type="bibr" rid="bibr26-1933719112442248">26</xref>
</sup> as PE (proliferative endometrium, days 8-14, n = 6), ESE (early secretory endometrium, days 15-18, n = 4), MSE (mid-secretory endometrium, days 19-23, n = 5), and LSE (late secretory endometrium, days 24-28, n = 3).</p>
<p>Other portions were snap frozen in liquid nitrogen for RNA isolation before reverse transcription, and real-time polymerase chain reaction (PCR) were employed for validation of the selected genes. The primers were designed using online software Primer 3 at http://frodo.wi.mit.edu/ (<xref ref-type="table" rid="table2-1933719112442248">Table 2</xref>); the complementary DNA (cDNA) was generated using RevertAidTM First Strand cDNA Synthesis Kit (Fermentas, Canada) as indicated by the manufacturer’s protocol; quantitative PCR was performed with SYBR Premix Ex Taq (Takara, China), detected by ABI PRISM 7500HT system (Applied Biosystem, California, USA); and the gene expressions of selected genes, normalized to those of the glyceraldehyde-3-phosphate dehydrogenase in all samples. All experiments were performed in triplicate.</p>
<table-wrap id="table2-1933719112442248" position="float">
<label>Table 2.</label>
<caption>
<p>Primers Used for Real-Time PCR Validation</p>
</caption>
<graphic alternate-form-of="table2-1933719112442248" xlink:href="10.1177_1933719112442248-table2.tif"/>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Forward </th>
<th>Reverse</th>
<th>Amplicon (bp)</th>
</tr>
</thead>
<tbody>
<tr>
<td>GAPDH</td>
<td>GTGGACCTGACCTGCCGTCT</td>
<td>GGAGGAGTGGGTGTCGCTGT</td>
<td>153</td>
</tr>
<tr>
<td>DKK1</td>
<td>TCCGAGGAGAAATTGAGGAA</td>
<td>CCTGAGGCACAGTCTGATGA</td>
<td>157</td>
</tr>
<tr>
<td>S100P</td>
<td>TACCAGGCTTCCTGCAGAGT</td>
<td>AGGGCATCATTTGAGTCCTG</td>
<td>173</td>
</tr>
<tr>
<td>FAM148A</td>
<td>CAACATGCATGGAGACCATC</td>
<td>CCGCCACACCTAGCCTATTA</td>
<td>237</td>
</tr>
<tr>
<td>MAOA</td>
<td>CACACCTTTTGGGAAATGCT</td>
<td>TGGACTGGCATTCATTTTGA</td>
<td>204</td>
</tr>
<tr>
<td>SFRP4</td>
<td>GCCTGGGACAGCCTATGTAA</td>
<td>GCAATAAGCCTTTTCCACCA</td>
<td>194</td>
</tr>
<tr>
<td>CXCL14</td>
<td>TCCGGTCAGCATGAGGCTCC</td>
<td>CACCCTATTCTTCGTAGACC</td>
<td>313</td>
</tr>
<tr>
<td>CRISP3</td>
<td>GCTGCTTCCATCTTTTCCAG</td>
<td>ATTTGCTGCAGCCTCTTTGT</td>
<td>178</td>
</tr>
<tr>
<td>ANXA4</td>
<td>TAAATCGATGAAGGGCTTGG</td>
<td>AGGCAGCTGTAGGCGTTTTA</td>
<td>320</td>
</tr>
<tr>
<td>SFN</td>
<td>GGATCCCACTCTTCTTGCAG</td>
<td>CTGTCCAGTTCTCAGCCACA</td>
<td>192</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1933719112442248">
<p>Abbreviation: PCR, polymerase chain reaction.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Genes were selected for validation because of their highly significant <italic>P </italic>value or FC (fold change) and/or because more than one probe set of the same gene whose expressions were significantly different. The selection occurred also on the ground of previously published data on gene expression studies related to endometrial receptivity.</p>
<p>Data analysis was conducted using the relative expression algorithm, and statistical analysis was performed via one-way analysis of variance followed by LSD (least significant difference) analysis with SPSS 16.0 software. The values were considered statistically significant at <italic>P </italic>≤ .05.</p>
</sec>
</sec>
<sec id="section9-1933719112442248">
<title>Results</title>
<sec id="section10-1933719112442248">
<title>Expression Analysis of Genes in MSE</title>
<p>When a minimal change of 2-fold was adopted as the threshold, 1543 of 54 675 gene sets were identified to express differentially in MSE. The PCA of the expression profiles demonstrated a clear segregation of PE from the other 3 secretory phases, and the distance between MSE and LSE was closer than that between ESE and MSE (<xref ref-type="fig" rid="fig1-1933719112442248">Figure 1</xref>).</p>
<fig id="fig1-1933719112442248" position="float">
<label>Figure 1.</label>
<caption>
<p>Principal components analysis (PCA) using the genes with over 2-fold change through the 4 menstrual phases. Expression between PE and the other 3 secretory phases was distinguishable along the first principal components axis, whereas the others were defined by the second principal components axis, and the distance between MSE and LSE was closer than that between ESE and MSE. PE indicates proliferative endometrium; ESE, early secretory endometrium; MSE, mid-secretory endometrium; LSE, late secretory endometrium.</p>
</caption>
<graphic alternate-form-of="fig1-1933719112442248" xlink:href="10.1177_1933719112442248-fig1.tif"/>
</fig>
<p>Hierarchical cluster analysis identified the profile of the spatial–temporal expression of genes, of which 999 were upregulated and 544 were downregulated in MSE (<xref ref-type="fig" rid="fig2-1933719112442248">Figure 2</xref>). When the threshold was adjusted to a 5-fold change, a total of 148 gene sets, 73 up- and 75 downregulated, were listed as candidate biomarkers of the endometrium in MSE (<xref ref-type="table" rid="table3-1933719112442248">Tables 3</xref> and <xref ref-type="table" rid="table4-1933719112442248">4</xref>).</p>
<table-wrap id="table3-1933719112442248" position="float">
<label>Table 3.</label>
<caption>
<p>The Genes Changed More Than 5-Fold and With the Highest Expression in MSE<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table3-1933719112442248" xlink:href="10.1177_1933719112442248-table3.tif"/>
<graphic alternate-form-of="table3-1933719112442248" xlink:href="10.1177_1933719112442248-table3a.tif"/>
<table>
<thead>
<tr>
<th>Gene Identifier</th>
<th>Symbol</th>
<th>Gene Title</th>
</tr>
</thead>
<tbody>
<tr>
<td>AF237813</td>
<td>ABAT</td>
<td>4-aminobutyrate aminotransferase</td>
</tr>
<tr>
<td>NM_001099</td>
<td>ACPP</td>
<td>Acid phosphatase, prostate</td>
</tr>
<tr>
<td>AC004010</td>
<td>AMIGO2</td>
<td>Adhesion molecule with Ig-like domain 2</td>
</tr>
<tr>
<td>AI935123</td>
<td>AHNAK</td>
<td>AHNAK nucleoprotein 2</td>
</tr>
<tr>
<td>NM_001159</td>
<td>AOX1</td>
<td>Aldehyde oxidase 1</td>
</tr>
<tr>
<td>AI761728</td>
<td>ANG</td>
<td>Angiogenin, ribonuclease, RNase A family, 5</td>
</tr>
<tr>
<td>NM_001153</td>
<td>ANXA4</td>
<td>Annexin A4</td>
</tr>
<tr>
<td>AF323540</td>
<td>APOL1</td>
<td>Apolipoprotein L, 1</td>
</tr>
<tr>
<td>NM_001172</td>
<td>
<bold>ARG2</bold>
</td>
<td>
<bold>Arginase, type II</bold> (14.6)</td>
</tr>
<tr>
<td>NM_020037</td>
<td>ABCC3</td>
<td>ATP-binding cassette, sub-family C (CFTR/MRP), member 3</td>
</tr>
<tr>
<td>NM_001706</td>
<td>BCL6</td>
<td>B-cell CLL/lymphoma 6</td>
</tr>
<tr>
<td>NM_024764</td>
<td>CATSPERB</td>
<td>Cation channel, sperm-associated, beta</td>
</tr>
<tr>
<td>AF109161</td>
<td>CITED2</td>
<td>Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2</td>
</tr>
<tr>
<td>NM_000574</td>
<td>
<bold>CD55</bold>
</td>
<td>
<bold>CD55 molecule, decay accelerating factor for complement </bold>(16.2)</td>
</tr>
<tr>
<td>BF594323</td>
<td>LOC138295</td>
<td>CDNA FLJ37936 fis<sup>b</sup>
</td>
</tr>
<tr>
<td>AI684991</td>
<td>
<bold>CP</bold>
</td>
<td>
<bold>Ceruloplasmin (ferroxidase) </bold>(15.9)<sup>b</sup>
</td>
</tr>
<tr>
<td>AI927990</td>
<td>
<bold>CXCL14</bold>
</td>
<td>
<bold>Chemokine (C-X-C motif) ligand 14 </bold>(88.4)<sup>b</sup>
</td>
</tr>
<tr>
<td>AI302100</td>
<td>C10orf10</td>
<td>Chromosome 10 open reading frame 10</td>
</tr>
<tr>
<td>NM_001305</td>
<td>CLDN4</td>
<td>Claudin 4</td>
</tr>
<tr>
<td>NM_001928</td>
<td>
<bold>CFD</bold>
</td>
<td>
<bold>Complement factor D (adipsin) </bold>(14.6)</td>
</tr>
<tr>
<td>AF007162</td>
<td>CRYAB</td>
<td>Crystallin, alpha B</td>
</tr>
<tr>
<td>NM_006061</td>
<td>
<bold>CRISP3</bold>
</td>
<td>
<bold>Cysteine-rich secretory protein 3</bold> (52.6)</td>
</tr>
<tr>
<td>U73945</td>
<td>
<bold>DEFB1</bold>
</td>
<td>
<bold>Defensin, beta 1</bold> (13.3)</td>
</tr>
<tr>
<td>BF059512</td>
<td>DNER</td>
<td>Delta/notch-like EGF repeat containing</td>
</tr>
<tr>
<td>NM_012242</td>
<td>
<bold>DKK1</bold>
</td>
<td>
<bold>Dickkopf homolog 1 (Xenopus laevis)</bold> (38.2)</td>
</tr>
<tr>
<td>NM_006520</td>
<td>DYNLT3</td>
<td>Dynein, light chain, Tctex-type 3</td>
</tr>
<tr>
<td>AW138767</td>
<td>ELOVL7</td>
<td>ELOVL family member 7, elongation of long chain fatty acids (yeast)</td>
</tr>
<tr>
<td>BE218239</td>
<td>
<bold>FAM148A</bold>
</td>
<td>
<bold>Family with sequence similarity 148, member A</bold> (94.9)</td>
</tr>
<tr>
<td>AI346522</td>
<td>
<bold>FAM148B</bold>
</td>
<td>
<bold>Family with sequence similarity 148, member B</bold> (10.3)</td>
</tr>
<tr>
<td>AL039862</td>
<td>FAM84B</td>
<td>Family with sequence similarity 84, member B</td>
</tr>
<tr>
<td>AF180519</td>
<td>GABARAPL3</td>
<td>GABA(A) receptors associated protein like 3 (pseudogene)</td>
</tr>
<tr>
<td>NM_017577</td>
<td>GRAMD1C</td>
<td>GRAM domain containing 1C</td>
</tr>
<tr>
<td>NM_004120</td>
<td>GBP2</td>
<td>Guanylate binding protein 2, interferon-inducible</td>
</tr>
<tr>
<td>NM_006665</td>
<td>HPSE</td>
<td>Heparanase</td>
</tr>
<tr>
<td>NM_000585</td>
<td>IL15</td>
<td>Interleukin 15</td>
</tr>
<tr>
<td>AI681917</td>
<td>
<bold>IRX3</bold>
</td>
<td>
<bold>Iroquois homeobox 3</bold> (25.3)</td>
</tr>
<tr>
<td>BC002700</td>
<td>KRT7</td>
<td>Keratin 7</td>
</tr>
<tr>
<td>BU683415</td>
<td>KLF6</td>
<td>Kruppel-like factor 6</td>
</tr>
<tr>
<td>NM_020997</td>
<td>
<bold>LEFTY1</bold>
</td>
<td>
<bold>Left–right determination factor 1 </bold>(16.5)</td>
</tr>
<tr>
<td>AI797263</td>
<td>LIMS3</td>
<td>LIM and senescent cell antigen-like domains 3</td>
</tr>
<tr>
<td>AL542291</td>
<td>
<bold>MFSD4</bold>
</td>
<td>
<bold>Major facilitator superfamily domain containing 4</bold> (12.6)<sup>b</sup>
</td>
</tr>
<tr>
<td>R06655</td>
<td>
<bold>MT1M</bold>
</td>
<td>
<bold>Metallothionein 1M</bold> (44.2)</td>
</tr>
<tr>
<td>AW665892</td>
<td>MFAP5</td>
<td>Microfibrillar-associated protein 5<sup>b</sup>
</td>
</tr>
<tr>
<td>AA923354</td>
<td>
<bold>MAOA</bold>
</td>
<td>
<bold>Monoamine oxidase A </bold>(18.1)<sup>b</sup>
</td>
</tr>
<tr>
<td>AI452798</td>
<td>
<bold>MYOCD</bold>
</td>
<td>
<bold>Myocardin </bold>(13.8)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_005384</td>
<td>MFIL3</td>
<td>Nuclear factor, interleukin 3 regulated</td>
</tr>
<tr>
<td>AI829726</td>
<td>
<bold>PHYHIPL</bold>
</td>
<td>
<bold>Phytanoyl-CoA 2-hydroxylase interacting protein-like </bold>(10.1)</td>
</tr>
<tr>
<td>NM_002849</td>
<td>PTPRR</td>
<td>Protein tyrosine phosphatase, receptor type, R<sup>b</sup>
</td>
</tr>
<tr>
<td>AB002365</td>
<td>PRUNE</td>
<td>Prune homolog 2 (Drosophila)</td>
</tr>
<tr>
<td>BG054987</td>
<td>RHPN2</td>
<td>Rhophilin, Rho GTPase-binding protein 2</td>
</tr>
<tr>
<td>AI760919</td>
<td>
<bold>RIMKLB</bold>
</td>
<td>
<bold>Ribosomal modification protein rimK-like family member B</bold> (15.4)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_005980</td>
<td>
<bold>S100P</bold>
</td>
<td>
<bold>S100 calcium binding protein P</bold> (39.2)</td>
</tr>
<tr>
<td>NM_002411</td>
<td>
<bold>SCGB2A2</bold>
</td>
<td>
<bold>Secretoglobin, family 2A, member 2 </bold>(38.5)</td>
</tr>
<tr>
<td>NM_000062</td>
<td>SERPING1</td>
<td>Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1</td>
</tr>
<tr>
<td>NM_004170</td>
<td>SLC1A1</td>
<td>Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1</td>
</tr>
<tr>
<td>NM_005073</td>
<td>
<bold>SLC15A1</bold>
</td>
<td>
<bold>Solute carrier family 15, member 1 </bold>(18.6)</td>
</tr>
<tr>
<td>NM_004207</td>
<td>SLC16A3</td>
<td>Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)<sup>b</sup>
</td>
</tr>
<tr>
<td>AI269290</td>
<td>
<bold>SLC18A2</bold>
</td>
<td>
<bold>Solute carrier family 18 (vesicular monoamine), member 2 </bold>(11.1)<sup>b</sup>
</td>
</tr>
<tr>
<td>M95548</td>
<td>
<bold>SLC3</bold>
</td>
<td>
<bold>Solute carrier family 3</bold> (43.2)</td>
</tr>
<tr>
<td>AF146796</td>
<td>SLC34A2</td>
<td>Solute carrier family 34 (sodium phosphate), member 2</td>
</tr>
<tr>
<td>AW165999</td>
<td>SLC44A1</td>
<td>Solute carrier family 44, member 1</td>
</tr>
<tr>
<td>NM_025257</td>
<td>SLC44A4</td>
<td>Solute carrier family 44, member 4<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_016354</td>
<td>SLCO4A1</td>
<td>Solute carrier organic anion transporter family, member 4A1</td>
</tr>
<tr>
<td>NM_003155</td>
<td>STC1</td>
<td>Stanniocalcin 1<sup>b</sup>
</td>
</tr>
<tr>
<td>BC002480</td>
<td>SRD5A3</td>
<td>Steroid 5 alpha-reductase 3<sup>b</sup>
</td>
</tr>
<tr>
<td>AL136531</td>
<td>SDCBP2</td>
<td>Syndecan-binding protein (syntenin) 2</td>
</tr>
<tr>
<td>NM_152332</td>
<td>TC2N</td>
<td>Tandem C2 domains, nuclear</td>
</tr>
<tr>
<td>NM_004616</td>
<td>TSPAN8</td>
<td>Tetraspanin 8</td>
</tr>
<tr>
<td>AI272941</td>
<td>TRPM8</td>
<td>Transient receptor potential cation channel, subfamily M, member 8</td>
</tr>
<tr>
<td>NM_024780</td>
<td>TMC5</td>
<td>Transmembrane channel-like 5<sup>b</sup>
</td>
</tr>
<tr>
<td>AW242836</td>
<td>TMEM45B</td>
<td>Transmembrane protein 45B</td>
</tr>
<tr>
<td>BG120535</td>
<td>
<bold>VNN1</bold>
</td>
<td>
<bold>Vanin 1 </bold>(20.9)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_020119</td>
<td>ZC3HAV1</td>
<td>Zinc finger CCCH-type, antiviral 1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1933719112442248">
<p>Abbreviation: MSE middle secretory endometrium.</p>
</fn>
<fn id="table-fn4-1933719112442248">
<p>
<sup>a</sup> All the genes were listed by alphabetic order. The genes over 10-fold change are in boldface, and the number in the parentheses indicated the fold change.</p>
</fn>
<fn id="table-fn5-1933719112442248">
<p>
<sup>b</sup> More than 1 gene set of the corresponding genes significantly changed.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-1933719112442248" position="float">
<label>Figure 2.</label>
<caption>
<p>Gene expression profiles showing the spacial–temporary upregulated (A) and downregulated (B) genes in MSE, the data normalized to the signal intensity of PE, hierarchical clustering of the 999 especially upregulated transcripts (C) and 544 downregulated transcripts (D) displayed as a color tree, with branch length reflecting the degree of similarity between the genes and with different colors reflecting the expression intensity through the menstrual cycle. The genes were meeting the 2-fold change cutoff of log ratio with a <italic>P</italic> &lt; .05.</p>
</caption>
<graphic alternate-form-of="fig2-1933719112442248" xlink:href="10.1177_1933719112442248-fig2.tif"/>
</fig>
<table-wrap id="table4-1933719112442248" position="float">
<label>Table 4.</label>
<caption>
<p>The Genes Changed More Than 5-Fold and With the Lowest Expression Level in MSE<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table4-1933719112442248" xlink:href="10.1177_1933719112442248-table4.tif"/>
<graphic alternate-form-of="table4-1933719112442248" xlink:href="10.1177_1933719112442248-table4a.tif"/>
<table>
<thead>
<tr>
<th>Gene Identifier</th>
<th>Gene Title</th>
<th>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>NM_003474</td>
<td>
<bold>ADAM12</bold>
</td>
<td>
<bold>ADAM metallopeptidase domain 12</bold> (−13.7)<sup>b</sup>
</td>
</tr>
<tr>
<td>AK023208</td>
<td>ANLN</td>
<td>Anillin, actin-binding protein<sup>b</sup>
</td>
</tr>
<tr>
<td>AI307802</td>
<td>ANKRD29</td>
<td>Ankyrin repeat domain 29</td>
</tr>
<tr>
<td>BF589515</td>
<td>ANO4</td>
<td>Anoctamin 4</td>
</tr>
<tr>
<td>NM_004900</td>
<td>APOBEC3B</td>
<td>Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B</td>
</tr>
<tr>
<td>AW519141</td>
<td>ARMCX4</td>
<td>Armadillo repeat containing, X-linked 4</td>
</tr>
<tr>
<td>NM_018123</td>
<td>ASPM</td>
<td>asp (abnormal spindle) homolog, microcephaly associated (Drosophila)</td>
</tr>
<tr>
<td>AA905217</td>
<td>ATP8B3</td>
<td>ATPase, class I, type 8B, member 3</td>
</tr>
<tr>
<td>NM_000702</td>
<td>ATP1A2</td>
<td>ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide</td>
</tr>
<tr>
<td>NM_001211</td>
<td>BUB1B</td>
<td>Budding uninhibited by benzimidazoles 1 homolog beta (yeast)</td>
</tr>
<tr>
<td>AI469884</td>
<td>CPM</td>
<td>Carboxypeptidase M<sup>b</sup>
</td>
</tr>
<tr>
<td>AL519710</td>
<td>CADM1</td>
<td>Cell adhesion molecule 1</td>
</tr>
<tr>
<td>AL524035</td>
<td>CDC2</td>
<td>Cell division cycle 2, G1 to S and G2 to M</td>
</tr>
<tr>
<td>NM_001255</td>
<td>FLJ37927</td>
<td>Cell division cycle 20 homolog (<italic>S. cerevisiae</italic>)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_001878</td>
<td>CRABP2</td>
<td>Cellular retinoic acid-binding protein 2</td>
</tr>
<tr>
<td>NM_001809</td>
<td>CENPA</td>
<td>Centromere protein A</td>
</tr>
<tr>
<td>BC005400</td>
<td>CENPK</td>
<td>Centromere protein K</td>
</tr>
<tr>
<td>NM_018131</td>
<td>CEP55</td>
<td>Centrosomal protein 55 kDa</td>
</tr>
<tr>
<td>NM_004772</td>
<td>C5orf13</td>
<td>Chromosome 5 open reading frame 13<sup>b</sup>
</td>
</tr>
<tr>
<td>AK021957</td>
<td>COL27A1</td>
<td>Collagen, type XXVII, alpha 1</td>
</tr>
<tr>
<td>BE407516</td>
<td>CCNB1</td>
<td>Cyclin B1<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_004701</td>
<td>CCNB2</td>
<td>Cyclin B2</td>
</tr>
<tr>
<td>NM_013989</td>
<td>DIO2</td>
<td>Deiodinase, iodothyronine, type II<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_013253</td>
<td>DKK3</td>
<td>Dickkopf homolog 3<sup>b</sup>
</td>
<td>
</td>
</tr>
<tr>
<td>AW071705</td>
<td>DPP6</td>
<td>Dipeptidyl-peptidase 6</td>
</tr>
<tr>
<td>NM_014750</td>
<td>DLGAP5</td>
<td>Discs, large (Drosophila) homolog-associated protein 5</td>
</tr>
<tr>
<td>AF010314</td>
<td>ENC1</td>
<td>Ectodermal-neural cortex (with BTB-like domain)</td>
</tr>
<tr>
<td>BE881590</td>
<td>ETV1</td>
<td>Ets variant 1</td>
</tr>
<tr>
<td>NM_001999</td>
<td>FBN2</td>
<td>Fibrillin 2</td>
</tr>
<tr>
<td>NM_023067</td>
<td>FOXL2</td>
<td>Forkhead box L2</td>
</tr>
<tr>
<td>AI824037</td>
<td>FREM1</td>
<td>FRAS1-related extracellular matrix 1</td>
</tr>
<tr>
<td>NM_021067</td>
<td>GINS1</td>
<td>GINS complex subunit 1 (Psf1 homolog)</td>
</tr>
<tr>
<td>NM_001498</td>
<td>GCLC</td>
<td>Glutamate-cysteine ligase, catalytic subunit</td>
</tr>
<tr>
<td>W63754</td>
<td>GLT8D2</td>
<td>Glycosyltransferase 8 domain containing 2</td>
</tr>
<tr>
<td>NM_018063</td>
<td>HELLS</td>
<td>Helicase, lymphoid specific</td>
</tr>
<tr>
<td>AA628967</td>
<td>IHH</td>
<td>Indian hedgehog homolog (Drosophila)</td>
</tr>
<tr>
<td>NM_014736</td>
<td>KIAA0101</td>
<td>KIAA0101</td>
</tr>
<tr>
<td>AB018345</td>
<td>KIAA0802</td>
<td>KIAA0802</td>
</tr>
<tr>
<td>NM_004523</td>
<td>KIF11</td>
<td>Kinesin family member 11</td>
</tr>
<tr>
<td>NM_005733</td>
<td>KIF20A</td>
<td>Kinesin family member 20A</td>
</tr>
<tr>
<td>NM_003679</td>
<td>KMO</td>
<td>Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_005573</td>
<td>LMNB1</td>
<td>Lamin B1</td>
</tr>
<tr>
<td>NM_002358</td>
<td>MAD2L1</td>
<td>MAD2 mitotic arrest deficient-like 1 (yeast)</td>
</tr>
<tr>
<td>NM_005940</td>
<td>
<bold>MMP11</bold>
</td>
<td>
<bold>Matrix metallopeptidase 11</bold> <bold>(stromelysin 3)</bold> (−16.5)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_002423</td>
<td>
<bold>MMP7</bold>
</td>
<td>
<bold>Matrix metallopeptidase 7(matrilysin, uterine)</bold> (−11.1)</td>
</tr>
<tr>
<td>AF245505</td>
<td>MXRA5</td>
<td>Matrix-remodelling associated 5</td>
</tr>
<tr>
<td>NM_024629</td>
<td>MLF1IP</td>
<td>MLF1 interacting protein</td>
</tr>
<tr>
<td>D31771</td>
<td>MSX2 </td>
<td>Msh homeobox 2<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_006101</td>
<td>NDC80</td>
<td>NDC80 homolog, kinetochore complex component (S. cerevisiae)</td>
</tr>
<tr>
<td>BF196935</td>
<td>NPAS3</td>
<td>Neuronal PAS domain protein 3<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_016359</td>
<td>NUSAP1</td>
<td>Nucleolar and spindle associated protein 1</td>
</tr>
<tr>
<td>NM_006334</td>
<td>OLFM1</td>
<td>Olfactomedin 1</td>
</tr>
<tr>
<td>BG054916</td>
<td>PTCH</td>
<td>Patched homolog 1 (Drosophila)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_018492</td>
<td>PBK</td>
<td>PDZ-binding kinase </td>
</tr>
<tr>
<td>D13665</td>
<td>POSTN</td>
<td>Periostin, osteoblast specific factor<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_018215</td>
<td>PNMAL1</td>
<td>PNMA-like 1</td>
</tr>
<tr>
<td>NM_006211</td>
<td>PENK</td>
<td>Proenkephalin</td>
</tr>
<tr>
<td>NM_000926</td>
<td>PGR</td>
<td>Progesterone receptor</td>
</tr>
<tr>
<td>NM_006200</td>
<td>
<bold>PCSK5</bold>
</td>
<td>
<bold>Proprotein convertase subtilisin/kexin type 5 </bold>(−10.9)<sup>b</sup>
</td>
</tr>
<tr>
<td>AF086924</td>
<td>PPP2R2C</td>
<td>Protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform *</td>
</tr>
<tr>
<td>AI733027</td>
<td>RBP7</td>
<td>Retinol-binding protein 7, cellular</td>
</tr>
<tr>
<td>BC001886</td>
<td>RRM2</td>
<td>Ribonucleotide reductase M2 polypeptide<sup>b</sup>
</td>
</tr>
<tr>
<td>N23651</td>
<td>SDK2</td>
<td>Sidekick homolog 2</td>
</tr>
<tr>
<td>NM_018242</td>
<td>SLC47A1</td>
<td>Solute carrier family 47, member 1</td>
</tr>
<tr>
<td>NM_002160</td>
<td>TNC</td>
<td>Tenascin C</td>
</tr>
<tr>
<td>NM_001071</td>
<td>TYMS</td>
<td>Thymidylate synthetase<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_021992</td>
<td>TMSB15A</td>
<td>Thymosin beta 15a</td>
</tr>
<tr>
<td>AU159942</td>
<td>
<bold>TOP2A</bold>
</td>
<td>
<bold>Topoisomerase (DNA) II alpha 170kDa </bold>(−10.4)<sup>b</sup>
</td>
</tr>
<tr>
<td>AL521682</td>
<td>TMEM119</td>
<td>Transmembrane protein 119</td>
</tr>
<tr>
<td>NM_024714</td>
<td>TMEM120B</td>
<td>Transmembrane protein 120B</td>
</tr>
<tr>
<td>NM_021643</td>
<td>TRIB2</td>
<td>Tribbles homolog 2 (Drosophila)<sup>b</sup>
</td>
</tr>
<tr>
<td>NM_003318</td>
<td>TTK</td>
<td>TTK protein kinase</td>
</tr>
<tr>
<td>AK025578</td>
<td>UHRF1</td>
<td>Ubiquitin-like with PHD and ring finger domains 1</td>
</tr>
<tr>
<td>NM_021197</td>
<td>WFDC1</td>
<td>WAP 4-disulfide core domain 1</td>
</tr>
<tr>
<td>N62196</td>
<td>ZNF367</td>
<td>Zinc finger protein 367</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1933719112442248">
<p>Abbreviations: MSE middle secretory endometrium; mRNA, messenger RNA.</p>
</fn>
<fn id="table-fn7-1933719112442248">
<p>
<sup>a</sup> All the genes were listed by alphabetic order. The genes over 10-fold change are in boldface, and the number in the parentheses indicated the fold change.</p>
</fn>
<fn id="table-fn8-1933719112442248">
<p>
<sup>b</sup> More than 1 gene set of the corresponding genes changed.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The chromosome analysis found that the differentially expressed genes distributed in chromosomes 4, 9, and 14 with a high <italic>z</italic> score &gt;2, indicating that more genes were located in these 3 chromosomes than expected by chance (<xref ref-type="table" rid="table5-1933719112442248">Table 5</xref>).</p>
<table-wrap id="table5-1933719112442248" position="float">
<label>Table 5.</label>
<caption>
<p>The Chromosome Analysis of the Differentially Expressed Genes</p>
</caption>
<graphic alternate-form-of="table5-1933719112442248" xlink:href="10.1177_1933719112442248-table5.tif"/>
<table>
<thead>
<tr>
<th align="center" colspan="4">Upregulated</th>
<th colspan="4">Downregulated</th>
</tr>
<tr>
<th>Chromosome</th>
<th>List</th>
<th>Gene Set</th>
<th>
<italic>z</italic> Score</th>
<th>Chromosome</th>
<th>List</th>
<th>Gene Set</th>
<th>
<italic>z</italic> Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>9</td>
<td>41</td>
<td>1174</td>
<td>2.83</td>
<td>4</td>
<td>33</td>
<td>1251</td>
<td>3.97</td>
</tr>
<tr>
<td>14</td>
<td>30</td>
<td>885</td>
<td>2.23</td>
<td>9</td>
<td>24</td>
<td>1174</td>
<td>2.05</td>
</tr>
<tr>
<td>11</td>
<td>47</td>
<td>1568</td>
<td>1.94</td>
<td>8</td>
<td>23</td>
<td>1154</td>
<td>1.88</td>
</tr>
<tr>
<td>12</td>
<td>44</td>
<td>1487</td>
<td>1.79</td>
<td align="center">X</td>
<td>19</td>
<td>935</td>
<td>1.79</td>
</tr>
<tr>
<td>21</td>
<td>13</td>
<td>353</td>
<td>1.77</td>
<td>5</td>
<td>26</td>
<td>1396</td>
<td>1.64</td>
</tr>
<tr>
<td>4</td>
<td>36</td>
<td>1251</td>
<td>1.43</td>
<td>18</td>
<td>10</td>
<td>519</td>
<td>1.11</td>
</tr>
<tr>
<td>8</td>
<td>33</td>
<td>1154</td>
<td>1.33</td>
<td>13</td>
<td>11</td>
<td>662</td>
<td>0.67</td>
</tr>
<tr>
<td>16</td>
<td>31</td>
<td>1154</td>
<td>0.93</td>
<td>20</td>
<td>12</td>
<td>750</td>
<td>0.56</td>
</tr>
<tr>
<td>15</td>
<td>26</td>
<td>992</td>
<td>0.72</td>
<td>11</td>
<td>23</td>
<td>1568</td>
<td>0.36</td>
</tr>
<tr>
<td>1</td>
<td>71</td>
<td>2885</td>
<td>0.67</td>
<td>2</td>
<td>28</td>
<td>2085</td>
<td>−0.09</td>
</tr>
<tr>
<td>6</td>
<td>39</td>
<td>1557</td>
<td>0.6</td>
<td>15</td>
<td>13</td>
<td>992</td>
<td>−0.15</td>
</tr>
<tr>
<td>18</td>
<td>11</td>
<td>519</td>
<td>−0.25</td>
<td>14</td>
<td>11</td>
<td>885</td>
<td>−0.32</td>
</tr>
<tr>
<td>2</td>
<td>44</td>
<td>2085</td>
<td>−0.55</td>
<td>10</td>
<td>15</td>
<td>1219</td>
<td>−0.41</td>
</tr>
<tr>
<td>10</td>
<td>25</td>
<td>1219</td>
<td>−0.56</td>
<td>17</td>
<td>20</td>
<td>1610</td>
<td>−0.44</td>
</tr>
<tr>
<td>22</td>
<td>11</td>
<td>614</td>
<td>−0.83</td>
<td>6</td>
<td>19</td>
<td>1557</td>
<td>−0.5</td>
</tr>
<tr>
<td>7</td>
<td>29</td>
<td>1496</td>
<td>−0.92</td>
<td>12</td>
<td>18</td>
<td>1487</td>
<td>−0.53</td>
</tr>
<tr>
<td>17</td>
<td>31</td>
<td>1610</td>
<td>−0.99</td>
<td>1</td>
<td>35</td>
<td>2885</td>
<td>−0.74</td>
</tr>
<tr>
<td>13</td>
<td>11</td>
<td>662</td>
<td>−1.09</td>
<td>7</td>
<td>17</td>
<td>1496</td>
<td>−0.78</td>
</tr>
<tr>
<td>3</td>
<td>33</td>
<td>1761</td>
<td>−1.19</td>
<td>22</td>
<td>6</td>
<td>614</td>
<td>−0.84</td>
</tr>
<tr>
<td>20</td>
<td>11</td>
<td>750</td>
<td>−1.52</td>
<td>21</td>
<td>3</td>
<td>353</td>
<td>−0.84</td>
</tr>
<tr>
<td>X</td>
<td>12</td>
<td>935</td>
<td>−2.08</td>
<td>3</td>
<td>16</td>
<td>1761</td>
<td>−1.7</td>
</tr>
<tr>
<td>5</td>
<td>20</td>
<td>1396</td>
<td>−2.18</td>
<td>16</td>
<td>7</td>
<td>1154</td>
<td>−2.26</td>
</tr>
<tr>
<td>19</td>
<td>18</td>
<td>1598</td>
<td>−3.19</td>
<td>19</td>
<td>9</td>
<td>1598</td>
<td>−2.84</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-1933719112442248">
<p>
<sup>a</sup> The number in the column of list displays the amount of the differentially expressed genes located in the corresponding chromosome and the number in the column of gene set represents the amount of all genes existing in the microarray and located in the corresponding chromosome. The genes used for this analysis met the 2-fold cutoff of log ratio with a <italic>P</italic> value ≤.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-1933719112442248">
<title>Functional Analysis of the Differentially Expressed Genes in MSE</title>
<p>Gene ontology analysis of the upregulated genes manifested that they were mainly assembled in the following biological processes: responses to wounding, response to stimulus and stress, and inflammation; that their molecular functions included signal transducer activity, oxidoreductase activity, and cytoskeletal protein binding; and that their cellular components were primarily located at the plasma membrane, desmosome, extracellular region, and cell–cell junction. On the other hand, the downregulated genes were mainly assembled in these biological processes: cell cycle, cell division, and cytoskeleton organization; their molecular functions basically comprised microtubule motor activity, binding, and metallopeptidase activity; their cellular components mainly involved spindle, condensed chromosome, and microtubule cytoskeleton (<xref ref-type="table" rid="table6-1933719112442248">Table 6</xref>).</p>
<table-wrap id="table6-1933719112442248" position="float">
<label>Table 6.</label>
<caption>
<p>Enriched GO Categories of the Differentially Expressed Genes<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table6-1933719112442248" xlink:href="10.1177_1933719112442248-table6.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Biological Process </th>
<th>Molecular Function </th>
<th>Cellular Component</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="10">Up</td>
<td>Response to stimulus</td>
<td>Molecular transducer activity</td>
<td>Membrane</td>
</tr>
<tr>
<td>Response to wounding</td>
<td>Signal transducer activity</td>
<td>Plasma membrane</td>
</tr>
<tr>
<td>Inflammatory response</td>
<td>Receptor activity</td>
<td>Lateral plasma membrane</td>
</tr>
<tr>
<td>Response to organic substance</td>
<td>Receptor binding</td>
<td>Desmosome</td>
</tr>
<tr>
<td>Response to stress</td>
<td>Transmembrane receptor activity</td>
<td>Extracellular region</td>
</tr>
<tr>
<td>Defense response</td>
<td>Transmembrane transporter activity</td>
<td>Cell fraction</td>
</tr>
<tr>
<td>Gene silencing by RNA</td>
<td>Calcium ion binding</td>
<td>Insoluble fraction</td>
</tr>
<tr>
<td>Anatomical structure development</td>
<td>Substrate-specific transmembrane </td>
<td>Cell–cell junction</td>
</tr>
<tr>
<td>Enzyme-linked receptor protein signaling pathway</td>
<td>Transporter activity</td>
<td>Apical part of cell</td>
</tr>
<tr>
<td>Cell differentiation</td>
<td>Oxidoreductase activity</td>
<td>Apical junction complex</td>
</tr>
<tr>
<td rowspan="10">Down</td>
<td>Cell cycle</td>
<td>Microtubule motor activity</td>
<td>Spindle</td>
</tr>
<tr>
<td>M phase</td>
<td>Integrin binding</td>
<td>Condensed chromosome, </td>
</tr>
<tr>
<td>Mitotic cell cycle</td>
<td>Metallopeptidase activity</td>
<td>(centromeric region, kinetochore)</td>
</tr>
<tr>
<td>Cell division</td>
<td>Metalloendopeptidase activity</td>
<td>Microtubule cytoskeleton</td>
</tr>
<tr>
<td>Organelle organization</td>
<td>Extracellular matrix structural Constituent</td>
<td>Proteinaceous extracellular matrix</td>
</tr>
<tr>
<td>Cytoskeleton organization</td>
<td>Receptor binding</td>
<td>Intracellular </td>
</tr>
<tr>
<td>DNA metabolic process</td>
<td>ATP binding</td>
<td>nonmembrane-bounded organelle</td>
</tr>
<tr>
<td>Cell proliferation</td>
<td>Protein binding</td>
<td>Protein complex</td>
</tr>
<tr>
<td>Response to DNA damage stimulus</td>
<td>Nucleoside binding</td>
<td>Microtubule organizing center</td>
</tr>
<tr>
<td>Chromosome organization</td>
<td>Peptidase activity</td>
<td>Extracellular region</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-1933719112442248">
<p>
<sup>a</sup> Only the top 10 categories of each classification have been listed in this table. The genes used for this analysis met the 2-fold cutoff of log ratio with a <italic>P </italic>value ≤.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section12-1933719112442248">
<title>Canonical Pathway and Network Analysis</title>
<p>Two canonical pathways, complement system and mitotic roles of polo-like kinase (Plk) pathway, were found to be highly regulated in MSE. Furthermore, the genes that participated in the former were mainly upregulated, whereas those in the latter were downregulated together (<xref ref-type="fig" rid="fig3-1933719112442248">Figure 3</xref>). Two significant networks, mainly related to cardiovascular system and cancers, were generated using the highly regulated genes which changed over 10-fold (<xref ref-type="table" rid="table7-1933719112442248">Table 7</xref>, <xref ref-type="fig" rid="fig4-1933719112442248">Figure 4</xref>).</p>
<fig id="fig3-1933719112442248" position="float">
<label>Figure 3.</label>
<caption>
<p>Canonical pathway analysis of the differentially expressed genes. Ingenuity pathway analysis identifying 2 most significant pathways from the data set; (A) the mitotic roles of polo-like kinase pathway; (B) the complement system pathway; red: upregulated genes, green: downregulated genes, and white: genes with no changes. The genes were from GeneSifter meeting the 2-fold change cutoff of log ratio with a <italic>P</italic> &lt; .05.</p>
</caption>
<graphic alternate-form-of="fig3-1933719112442248" xlink:href="10.1177_1933719112442248-fig3.tif"/>
</fig>
<fig id="fig4-1933719112442248" position="float">
<label>Figure 4.</label>
<caption>
<p>A: network related to cardiovascular system development and function, organismal development, cellular growth, and proliferation; (B) network about cancer, reproductive system disease, and tumor morphology. Red: upregulated genes, green: downregulated genes, white: genes with no changes. The genes were from GeneSifter meeting the 10-fold change cutoff of log ratio with a <italic>P</italic> &lt; .05.</p>
</caption>
<graphic alternate-form-of="fig4-1933719112442248" xlink:href="10.1177_1933719112442248-fig4.tif"/>
</fig>
<table-wrap id="table7-1933719112442248" position="float">
<label>Table 7.</label>
<caption>
<p>Networks Indentified by the Ingenuity Pathway Analysis<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table7-1933719112442248" xlink:href="10.1177_1933719112442248-table7.tif"/>
<table>
<thead>
<tr>
<th>ID</th>
<th>Molecules in Network</th>
<th>Score</th>
<th>Focus Molecules</th>
<th>Top Functions</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>ACTA1, <bold>ADAM12</bold>, AKT1, <bold>CFD</bold>, CNN1, <bold>DEFB1</bold>, ERBB2, ERK1/2,<bold> IDO1</bold>, IFNG, IL4, IL13, IL1B, INHBA, IRF1, ITGB1, interferon a, JUNB, <bold>LEFTY1</bold>, <bold>MAOA</bold>, MMP3,<bold> MMP11</bold>, MYC, <bold>MYOCD</bold>, PLAU, SERPINE1, SMAD7, SMAD2/3, STAT1, TAGLN, TNF,<bold> TOP2A</bold>, TGFB1, TGFBR2, TP53</td>
<td>15</td>
<td>9</td>
<td>Cardiovascular system development and function, organismal development, cellular growth and proliferation</td>
</tr>
<tr>
<td>2</td>
<td>ALDH3A2,<bold> APOD</bold>, <bold>AQP3</bold>,<bold> C4BPA</bold>,<bold> CD55</bold>, CITED1, CREBL2, CTNNB1, DDX17, <bold>DKK1</bold>, DUSP9, ERBB2, ESR1, FSH, GOT1, <bold>HAL</bold>, Histone h3, HNF1A, HSD17B2, INHBB, KLK3, LH, MLL2, <bold>MMP7</bold>, MTIL, MT1X, MYC, PCK1, PTPRF, RAB33B,<bold> S100P</bold>, <bold>SCGB2A2</bold>, SGK1, TP53, TPM1</td>
<td>15</td>
<td>9</td>
<td>Cancer, reproductive system disease, tumor morphology</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn11-1933719112442248">
<p>
<sup>a</sup> The highly regulated genes are in boldface. The genes used for this analysis met the 10-fold cutoff of log ratio with a <italic>P </italic>value ≤ .05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section13-1933719112442248">
<title>Data Validation</title>
<p>Nine genes, <italic>DKK1, S100P, MAOA, FAM48A, CXCL14, SFRP4, SFN, ANXA4</italic>, and<italic> CRISP3</italic>, were chosen for validation by real-time PCR (<xref ref-type="fig" rid="fig5-1933719112442248">Figure 5</xref>). The results accorded with those from data mining.</p>
<fig id="fig5-1933719112442248" position="float">
<label>Figure 5.</label>
<caption>
<p>Expression profile of selected genes CXCL14 (a), FAM148A (b), MAOA (c), S100P (d), ANXA4 (e), SFN (f), CRISP3(g), DKK1(h), and SFRP4 (i) exhibited by GeneSifter after analyzing the 45 microarray samples; mRNA levels for CXCL14 (A), FAM148A (B), MAOA (C), S100P (D), D ANXA4 (E), SFN (F), CRISP3(G), DKK1(H), and SFRP4 (I) in samples from fertile women examined by quantitative PCR using GAPDH as the housekeeping gene. The results were normalized relative to that of PE (mean ± SD; *<italic>P</italic> &lt; .05). mRNA indicates messenger RNA; PCR, polymerase chain reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; SD, standard deviation.</p>
</caption>
<graphic alternate-form-of="fig5-1933719112442248" xlink:href="10.1177_1933719112442248-fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-1933719112442248">
<title>Discussion</title>
<p>In the present study, we integrated microarray data from multicenter for the first time to decipher gene expression profile, search for potential biomarkers, and explore the possible mechanism of the endometrial receptivity in the “window of implantation.”</p>
<sec id="section15-1933719112442248">
<title>The Advantages of Bioinformatics</title>
<p>Genomics and proteomics have been widely applied to the research on endometrial receptivity. Because of the nature of the data, for example, high technical variability, small sample volume, and high dimension size, the results of high-throughput data were not highly reliable, and there was only 1 single gene, secreted phosphoprotein 1 (osteopontin), which differentially expressed (upregulated) in all the 5 previous studies.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112442248">27</xref>
</sup> Bioinformatics made it possible to collect a total of 45 microarray samples of human endometrium from 3 independent studies.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112442248">17</xref>,<xref ref-type="bibr" rid="bibr22-1933719112442248">22</xref>,<xref ref-type="bibr" rid="bibr23-1933719112442248">23</xref>
</sup> The collection caused an increase in sample volume to some degree, the bioinformatics algorithm provided by GeneSifter and IPA solved the high-dimension disaster, and the results were more robust and credible than the data from the single center. In this study, we attempted to extract valuable information from the previous data which would not only avoid unnecessary redundancy but also reach a reliable conclusion.</p>
</sec>
<sec id="section16-1933719112442248">
<title>Microarray Data Mining for the Differentially Expressed Genes</title>
<p>In total, 1543 gene sets were identified as spatial–temporal expression in MSE and significantly varied 2-fold with respect to PE stage. The number of the differentially expressed genes we detected was larger than that of the previous studies using platform Affymetrix HG-U95A,<sup>
<xref ref-type="bibr" rid="bibr14-1933719112442248">14</xref>
<xref ref-type="bibr" rid="bibr15-1933719112442248"/>–<xref ref-type="bibr" rid="bibr16-1933719112442248">16</xref>,<xref ref-type="bibr" rid="bibr28-1933719112442248">28</xref>,<xref ref-type="bibr" rid="bibr29-1933719112442248">29</xref>
</sup> in which only 100 to 800 differentially expressed genes were found. The possible reason was that we used Affymetrix HG-U133A plus 2.0 with more well-characterized human genes than those of Affymetrix HG-U95A and with different false discovery rates.</p>
<p>The results of PCA indicated that the profile of gene expression accorded with the morphology and functional stages of the endometrium during the menstrual cycle. Consistent with previous studies, we detected that secreted phosphoprotein 1 (osteopontin) upregulated more than 12-fold in MSE in comparison with PE. However, it did not involve in our resultant list of highly upregulated genes for it peaked in LSE. This does not mean that osteopontin played no role in the endometrial receptivity because it significantly upregulated in MSE; however, it might not be a unique marker of the window of implantation, for it still rose after the implantation window. The same was true for leukemia inhibitory factor (LIF), a secreted glycoprotein widely considered to play an important role in the process of embryo implantation.<sup>
<xref ref-type="bibr" rid="bibr30-1933719112442248">30</xref>
<xref ref-type="bibr" rid="bibr31-1933719112442248"/>–<xref ref-type="bibr" rid="bibr32-1933719112442248">32</xref>
</sup> In the current study, LIF was also detected to peak in LSE but was not a desirable marker for the transient implantation window.</p>
<p>The results of hierarchical cluster manifested the expression profile of the genes, those regulating significantly and being specific in MSE as well (<xref ref-type="fig" rid="fig2-1933719112442248">Figure 2</xref>). In the list of the top regulated genes, some genes had previously been reported, such as S100 calcium-binding protein P.<sup>
<xref ref-type="bibr" rid="bibr33-1933719112442248">33</xref>,<xref ref-type="bibr" rid="bibr34-1933719112442248">34</xref>
</sup> Dickkopf homolog 1,<sup>
<xref ref-type="bibr" rid="bibr35-1933719112442248">35</xref>,<xref ref-type="bibr" rid="bibr36-1933719112442248">36</xref>
</sup> and monoamine oxidase A.<sup>
<xref ref-type="bibr" rid="bibr16-1933719112442248">16</xref>,<xref ref-type="bibr" rid="bibr36-1933719112442248">36</xref>
</sup> Although the mechanism of these genes in the process of endometrial receptivity remains unclear, their spatial–temporal expression in MSE indicated that as potential biomarkers they might be critical to endometrial receptivity.</p>
<p>On the other hand, some genes were rarely reported, such as FAM148A, whose expression level in MSE was nearly as high as 95-fold  in PE and as high as 1.7-fold in LSE. Both FAM148A and FAM148B, the 2 members of family with sequence similarity 148, also known as C2CD4A/C2CD4B (encoding C2 calcium-dependent domain containing 4) or NLF1/2 (encoding nuclear localized factor), were upregulated in MSE. They were located at 15q22.2 and encoded nuclear factors characterized by regulating and controlling cellular architecture.<sup>
<xref ref-type="bibr" rid="bibr37-1933719112442248">37</xref>
</sup> Functional roles of FAM148A/B-encoded proteins were not well defined, and the convincing proof of FAM148A/B involved in endometrial receptivity was lacking. However, the expression of FAM148A/B in epithelial cells had been shown to be increased by treatment with proinflammatory cytokines and thus enhancing vascular permeability.<sup>
<xref ref-type="bibr" rid="bibr38-1933719112442248">38</xref>
</sup>
</p>
<p>Another significantly upregulated group was solute carrier (SLC) family, a group of membrane transport proteins, in which 9 members—functioning as transporting gluamate, neutral amino acid, and proton oligopeptide—were found to increase over 5-fold (<xref ref-type="table" rid="table2-1933719112442248">Table 2</xref>), while only SLC family 47, member 1—functioning as multidrug and toxin extrusion—was significantly downregulated. Although the reports about the SLC groups related to endometrial receptivity were limited, several members of this family markedly changed in the window of implantation, suggesting that they might play a vital role in the process.</p>
</sec>
<sec id="section17-1933719112442248">
<title>The Functional Analysis of the Differentially Expressed Genes</title>
<p>The results of ontology and function analysis accorded with the morphological and physiological alterations of the endometrium on the window of implantation, during which the endometrium stopped thickening, became more vascular and edematous and the glands displayed enhanced secretory activity. Thus, many of these differentially expressed genes attached themselves to the diseases with the similar biological processes, such as cancer, reproductive system diseases, and gastrointestinal diseases.</p>
<p>The chromosome analysis revealed that the differentially expressed genes were assembled in chromosomes 4, 9, and 14. Many reports showed that abnormal chromosome could disturb the development of preimplantation embryo,<sup>
<xref ref-type="bibr" rid="bibr39-1933719112442248">39</xref>,<xref ref-type="bibr" rid="bibr40-1933719112442248">40</xref>
</sup> but limited publications reported the effect of chromosome on endometrial receptivity. It had been found that patients with a complete or partial deficiency of an X chromosome developed an increase in early implantation failure after oocyte donation, which indicated an inherent endometrial abnormality concerned with a deficiency of X-linked genes.<sup>
<xref ref-type="bibr" rid="bibr41-1933719112442248">41</xref>
</sup> Thus, it cannot exclude the possibility that chromosome and autosome may affect the endometrial receptivity, although it needs to be proved.</p>
</sec>
<sec id="section18-1933719112442248">
<title>The Canonical Pathways and Network Analysis</title>
<p>The analysis of canonical pathways revealed that the complement system, part of the innate immune system, has been widely activated. Many studies have shown that complement regulatory proteins were among the most highly regulated genes in mid-secretory endometrium.<sup><xref ref-type="bibr" rid="bibr14-1933719112442248">14</xref>,<xref ref-type="bibr" rid="bibr17-1933719112442248">17</xref>,<xref ref-type="bibr" rid="bibr35-1933719112442248">35</xref>,<xref ref-type="bibr" rid="bibr42-1933719112442248">42</xref>,<xref ref-type="bibr" rid="bibr43-1933719112442248">43</xref>
</sup> Recent studies have indicated that controlled local complement activation promoted embryo development and was involved in the physiological remodeling of the spiral arteries.<sup>
<xref ref-type="bibr" rid="bibr44-1933719112442248">44</xref>
</sup> The other highly regulated canonical pathway was mitotic roles of Plk pathway, but it was widely inactivated in contrast with the complement system. Polo-like kinases, a family of conserved serine/threonine kinases, were reported to be involved in the regulation of cell cycle progression through G2 and M (mitosis). The downregulation of genes in this pathway was in accordance with the results of functional analysis that the biological processes of downregulated genes were mainly directed to cell cycle.</p>
<p>Moreover, two significant networks, related to the cardiovascular system development and cancer, have been identified using the top regulated genes (over 10-fold). The two networks were found to include cell-signaling pathways such as the smad2/3 pathway, Erk 1/2 pathway, and Akt pathway, as well as cell-signaling molecules such as nuclear interferon gamma, histone H3, TP53, and so on. According to network theories and studies of yeast cells, the genes in a network center and having the maximum number of connections play a key regulatory role.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112442248">21</xref>
</sup> In our study, TGFB1, TNF, ERBB2, and FSH, CTNNB1, ESR1, located at the centers of the two networks, respectively, were highly connected. The findings can provide important clues for further studies of the mechanism of endometrial receptivity.</p>
<p>Real-time PCR validated that the selected genes exhibited a high consistence with GeneSifter results, which proved the veracity and feasibility of our methods. Within the validated genes, some were widely accepted; however, some were rarely mapped, such as FAM148A, ANAX4 (Annexin IV), SFN (stratifin, also known as 14-3-3 sigma), CRISP3 (cysteine-rich secretory protein 3), and SFRP4 (secreted frizzled-related protein 4). The expression profile of these genes can be of great importance to further studies.</p>
</sec>
</sec>
<sec id="section19-1933719112442248">
<title>Conclusions</title>
<p>In summary, our study took advantage of existing data from microarray database, using bioinformatics tools, exhibiting a series of potential biomarkers specific to receptive endometrium, exploring their functions, pathways, and networks to pursue the mechanism of endometrial receptivity, and finding chromosomes 4, 9, and 14 being highly related to endometrial receptivity. Real-time PCR validated the expressions of 9 genes and proved the veracity and feasibility of our methods. Our study initiated such research in a meaningful way, even though further studies are needed to substantiate the results for clinical applications.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112442248">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112442248">
<label>Funding</label>
<p>This work was supported by grants from the Natural Science Foundation of China (NSFC, 30271354) and Shanghai Medical Science Bootstrap Class Project (10411960600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112442248">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achache</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Revel</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Endometrial receptivity markers, the journey to successful embryo implantation</article-title>. <source>Hum Reprod Update</source>. <year>2006</year>;<volume>12</volume>(<issue>6</issue>):<fpage>731</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112442248">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilcox</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>CR</given-names>
</name>
</person-group>. <article-title>Time of implantation of the conceptus and loss of pregnancy</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>(<issue>23</issue>):<fpage>1796</fpage>–<lpage>1799</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112442248">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cakmak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Implantation failure: molecular mechanisms and clinical treatment</article-title>. <source>Hum Reprod Update</source>. <year>2010</year>;<volume>17</volume>(<issue>2</issue>):<fpage>242</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112442248">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salamonsen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hannan</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Dimitriadis</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Society for reproductive biology founders' lecture 2009. Preparing fertile soil: the importance of endometrial receptivity</article-title>. <source>Reprod Fertil Dev</source>. <year>2009</year>;<volume>21</volume>(<issue>7</issue>):<fpage>923</fpage>–<lpage>934</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112442248">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Casper</surname>
<given-names>RF</given-names>
</name>
</person-group>. <article-title>Pinopodes: a questionable role in endometrial receptivity</article-title>. <source>Hum Reprod Update</source>. <year>2009</year>;<volume>15</volume>(<issue>2</issue>):<fpage>229</fpage>–<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112442248">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porter</surname>
<given-names>MB</given-names>
</name>
</person-group>. <article-title>Ultrasound in assisted reproductive technology</article-title>. <source>Semin Reprod Med</source>. <year>2008</year>;<volume>26</volume>(<issue>3</issue>):<fpage>266</fpage>–<lpage>276</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112442248">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodaman</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Hormonal regulation of implantation</article-title>. <source>Obstet Gynecol Clin North Am</source>. <year>2004</year>;<volume>31</volume>(<issue>4</issue>):<fpage>745</fpage>–<lpage>766</lpage>, <fpage>ix</fpage>.</citation>
</ref>
<ref id="bibr8-1933719112442248">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Drakakis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Loutradis</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Uterine pinopodes as markers of the 'nidation window' in cycling women receiving exogenous oestradiol and progesterone</article-title>. <source>Hum Reprod</source>. <year>1995</year>;<volume>10</volume>(<issue>5</issue>):<fpage>1208</fpage>–<lpage>1213</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112442248">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lessey</surname>
<given-names>BA</given-names>
</name>
</person-group>. <article-title>The role of the endometrium during embryo implantation</article-title>. <source>Hum Reprod</source>. <year>2000</year>;<volume>15</volume>(<issue>suppl 6</issue>):<fpage>39</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112442248">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boomsma</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kavelaars</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eijkemans</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group> <article-title>Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity</article-title>. <source>Reprod Biomed Online</source>. <year>2009</year>;<volume>18</volume>(<issue>1</issue>):<fpage>85</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112442248">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Application of functional genomics to primate endometrium: insights into biological processes</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2006</year>;<volume>4</volume>(<issue>suppl 1</issue>):<fpage>S4</fpage>.</citation>
</ref>
<ref id="bibr12-1933719112442248">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Microarray expression profiling reveals candidate genes for human uterine receptivity</article-title>. <source>Am J Pharmacogenomics</source>. <year>2004</year>;<volume>4</volume>(<issue>5</issue>):<fpage>299</fpage>–<lpage>312</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112442248">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrido-Gomez</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dominguez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Proteomics of embryonic implantation</article-title>. <source>Handb Exp Pharmacol</source>. 2010;198(1):<fpage>67</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112442248">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kao</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Tulac</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Global gene profiling in human endometrium during the window of implantation</article-title>. <source>Endocrinology</source>. <year>2002</year>;<volume>143</volume>(<issue>6</issue>):<fpage>2119</fpage>–<lpage>2138</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112442248">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borthwick</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Charnock-Jones</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Tom</surname>
<given-names>BD</given-names>
</name>
<etal/>
</person-group> <article-title>Determination of the transcript profile of human endometrium</article-title>. <source>Mol Hum Reprod</source>. <year>2003</year>;<volume>9</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112442248">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirkin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Churikov</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>In search of candidate genes critically expressed in the human endometrium during the window of implantation</article-title>. <source>Hum Reprod</source>. <year>2005</year>;<volume>20</volume>(<issue>8</issue>):<fpage>2104</fpage>–<lpage>2117</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112442248">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talbi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>KC</given-names>
</name>
<etal/>
</person-group> <article-title>Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women</article-title>. <source>Endocrinology</source>. <year>2006</year>;<volume>147</volume>(<issue>3</issue>):<fpage>1097</fpage>–<lpage>1121</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112442248">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardiner-Garden</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Littlejohn</surname>
<given-names>TG</given-names>
</name>
</person-group>. <article-title>A comparison of microarray databases</article-title>. <source>Brief Bioinform</source>. <year>2001</year>;<volume>2</volume>(<issue>2</issue>):<fpage>143</fpage>–<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112442248">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Kozlowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>GeneSifter, not so blind after all</article-title>. <source>Pigment Cell Melanoma Res</source>. <year>2009</year>;<volume>22</volume>(<issue>5</issue>):<fpage>649</fpage>–<lpage>650</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112442248">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbanski</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Noriega</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Kohama</surname>
<given-names>SG</given-names>
</name>
</person-group>. <article-title>Gene expression profiling in the rhesus macaque: experimental design considerations</article-title>. <source>Methods</source>. <year>2009</year>;<volume>49</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112442248">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardell</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cervin</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Genes regulating molecular and cellular functions in noninfectious nonallergic rhinitis</article-title>. <source>Allergy</source>. <year>2009</year>;<volume>64</volume>(<issue>9</issue>):<fpage>1301</fpage>–<lpage>1308</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112442248">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burney</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Talbi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group> <article-title>Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis</article-title>. <source>Endocrinology</source>. <year>2007</year>;<volume>148</volume>(<issue>8</issue>):<fpage>3814</fpage>–<lpage>3826</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112442248">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hever</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Hevezi</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>;<volume>104</volume>(<issue>30</issue>):<fpage>12451</fpage>–<lpage>12456</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112442248">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Vaerenbergh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Van Lommel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ghislain</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression</article-title>. <source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume>(<issue>5</issue>):<fpage>1085</fpage>–<lpage>1091</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112442248">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvano</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>DR</given-names>
</name>
<etal/>
</person-group> <article-title>A network-based analysis of systemic inflammation in humans</article-title>. <source>Nature</source>. <year>2005</year>;<volume>437</volume>(<issue>7061</issue>):<fpage>1032</fpage>–<lpage>1037</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112442248">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noyes</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Hertig</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Rock</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Dating the endometrial biopsy</article-title>. <source>Am J Obstet Gynecol</source>. <year>1975</year>;<volume>122</volume>(<issue>2</issue>):<fpage>262</fpage>–<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112442248">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diedrich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fauser</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Devroey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Griesinger</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>The role of the endometrium and embryo in human implantation</article-title>. <source>Hum Reprod Update</source>. <year>2007</year>;<volume>13</volume>(<issue>4</issue>):<fpage>365</fpage>–<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112442248">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carson</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Lagow</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Thathiah</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening</article-title>. <source>Mol Hum Reprod</source>. <year>2002</year>;<volume>8</volume>(<issue>9</issue>):<fpage>871</fpage>–<lpage>879</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112442248">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riesewijk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Os</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology</article-title>. <source>Mol Hum Reprod</source>. <year>2003</year>;<volume>9</volume>(<issue>5</issue>):<fpage>253</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112442248">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aghajanova</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Leukemia inhibitory factor and human embryo implantation</article-title>. <source>Ann N Y Acad Sci</source>. <year>2004</year>;<volume>1034</volume>(1):<fpage>176</fpage>–<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112442248">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rackow</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>93</volume>(<issue>6</issue>):<fpage>2027</fpage>–<lpage>2034</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112442248">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutsukake</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tachikawa</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Knockdown of IGF-binding protein 7 inhibits transformation of the endometrial gland in an in vitro model</article-title>. <source>Mol Reprod Dev</source>. <year>2010</year>;<volume>77</volume>(<issue>3</issue>):<fpage>265</fpage>–<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112442248">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>XN</given-names>
</name>
</person-group>, <article-title>Song T, et al. [Gene expression profiles of peri-implantation endometrium in natural and superovulation cycles]</article-title>. <source>Zhonghua Yi Xue Za Zhi</source>. <year>2008</year>;<volume>88</volume>(<issue>33</issue>):<fpage>2343</fpage>–<lpage>2346</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112442248">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>XN</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>SY</given-names>
</name>
</person-group>. <article-title>Calcium-binding protein S100P is highly expressed during the implantation window in human endometrium</article-title>. <source>Fertil Steril</source>. <year>2009</year>;<volume>94</volume>(<issue>4</issue>):<fpage>1510</fpage>–<lpage>1518</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112442248">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tseng</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>MY</given-names>
</name>
<etal/>
</person-group> <article-title>Genome-based expression profiling as a single standardized microarray platform for the diagnosis of endometrial disorder: an array of 126-gene model</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>94</volume>(<issue>1</issue>):<fpage>114</fpage>–<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112442248">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dassen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Punyadeera</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kamps</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Progesterone regulation of implantation-related genes: new insights into the role of oestrogen</article-title>. <source>Cell Mol Life Sci</source>. <year>2007</year>;<volume>64</volume>(<issue>7-8</issue>):<fpage>1009</fpage>–<lpage>1032</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112442248">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamauchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B</article-title>. <source>Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>10</issue>):<fpage>864</fpage>–<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112442248">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warton</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>KK</given-names>
</name>
</person-group>. <article-title>A novel gene family induced by acute inflammation in endothelial cells</article-title>. <source>Gene</source>. <year>2004</year>;<volume>342</volume>(<issue>1</issue>):<fpage>85</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr39-1933719112442248">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farfalli</surname>
<given-names>VI</given-names>
</name>
<name>
<surname>Magli</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ferraretti</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Gianaroli</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Role of aneuploidy on embryo implantation</article-title>. <source>Gynecol Obstet Invest</source>. <year>2007</year>;<volume>64</volume>(<issue>3</issue>):<fpage>161</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr40-1933719112442248">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fauzdar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Halder</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>A preliminary study on chromosome aneuploidy &amp; mosaicism in early pre-implantation human embryo by fluorescence in situ hybridization</article-title>. <source>Indian J Med Res</source>. <year>2008</year>;<volume>128</volume>(<issue>3</issue>):<fpage>287</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr41-1933719112442248">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaron</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ochshorn</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Amit</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Patients with Turner's syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation</article-title>. <source>Fertil Steril</source>. <year>1996</year>;<volume>65</volume>(<issue>6</issue>):<fpage>1249</fpage>–<lpage>1252</lpage>.</citation>
</ref>
<ref id="bibr42-1933719112442248">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogawa Fonzar-Marana</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Ferriani</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>SG</given-names>
</name>
<etal/>
</person-group> <article-title>Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase</article-title>. <source>Fertil Steril</source>. <year>2006</year>;<volume>86</volume>(<issue>3</issue>):<fpage>758</fpage>–<lpage>761</lpage>.</citation>
</ref>
<ref id="bibr43-1933719112442248">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasty</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Lambris</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Lessey</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Pruksananonda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lyttle</surname>
<given-names>CR</given-names>
</name>
</person-group>. <article-title>Hormonal regulation of complement components and receptors throughout the menstrual cycle</article-title>. <source>Am J Obstet Gynecol</source>. <year>1994</year>;<volume>170</volume>(<issue>1 pt 1</issue>):<fpage>168</fpage>–<lpage>175</lpage>.</citation>
</ref>
<ref id="bibr44-1933719112442248">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bulla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Tedesco</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>The complement system in the pathophysiology of pregnancy</article-title>. <source>Mol Immunol</source>. <year>2006</year>;<volume>43</volume>(<issue>1-2</issue>):<fpage>68</fpage>–<lpage>77</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>